Lung cancer
Conditions
Interventions
None listed
Sponsors
First Department of Surgery, Tokyo Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients in whom LigaSure may be used during such surgery as pulmonary lobectomy and pulmonary segmentectomy 2)Patients aged 20 years or older 3)Patients scheduled to undergo pulmonary lobectomy and pulmonary segmentectomy 4)Patients with ECOG Performance Status 0 to 1 5)Patients with no history of ipsilateral open lung surgery 6)Patients with preserved major organ function 7)Patients who have provided written informed consent for participation in the study
Exclusion criteria
Exclusion criteria: 1)Patients with a history of chest injury or pulmonary lobectomy 2)Patients with non-curative resectable factors of pulmonary cancer such as pleural dissemination and malignant pleural effusion on opening the chest 3)Patients with active bacterial and/or fungal infections 4)Patients receiving continued systemic (oral or intravenous) steroids 5)Patients with uncontrolled diabetes mellitus (HbA1c > 8.0%) 6)Patients with impaired major organ function (CTCAE ver. 4.0 Grade ≥ 2) 7)Patients with a psychiatric disorder or psychiatric symptoms that would preclude participation in the study 8)Any other patients judged by the doctor in charge to be ineligible as subjects in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The success rate and results of sealing of pulmonary arteries (under 5 mm in diameter) | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of additional procedures to the sealed sites during surgery. The occurrence frequency of intraoperative and postoperative adverse events, the duration of drain placement, and the duration of hospitalization. | — |
Countries
Japan
Outcome results
None listed